SPOTLIGHT -
Poll
Author(s):
When acute, severe adverse effects from a pre-switch antipsychotic occurs, what strategy is recommended? Take the quiz and learn more.
April in Review: Updates on the Psychiatric Treatment Pipeline
Here's to a Psychedelic Revolution
Cobenfy as Add-On Treatment for Schizophrenia Fails to Meet Primary Endpoint in Phase 3 ARISE Trial
Treating ‘Morally Objectionable’ Patients
Treating Schizophrenia: Bringing Together Pharmacists and Clinicians for Patient Care
The Slow Road to Psychosis